Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 5, 2025
Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine TumorsKosma Woliński, Paweł Komarnicki, Adam Maciejewski, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|July 1, 2026
Frequency and Impact of Thyroid Hormone Abnormalities in COVID-19: An Observational Study at the Peak of the PandemicPaweł Komarnicki, Alicja Rajewska, Jolanta Tomczak, et al.
Journal of Clinical Medicine|October 14, 2022
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and FuturePaweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Endokrynologia Polska|July 22, 2021
Determination of neuron-specific enolase in patients with midgut-type tumour treated with somatostatin analoguesPaweł Gut, Agata Czarnywojtek, Nadia Sawicka-Gutaj, et al.
Endocrine Connections|August 8, 2023
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failurePaweł Komarnicki, Paweł Gut, Jan Musiałkiewicz, et al.
Endocrine Connections|August 29, 2025
Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumoursJan Musiałkiewicz, Marek Ruchała, Paweł Komarnicki, et al.
International Journal of Molecular Sciences|June 12, 2026
Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine TumorsJan Musiałkiewicz, Bartłomiej Budny, Aleksandra Anioła, et al.
Cancers|June 19, 2024
Serum β-hCG as a Biomarker in Pancreatic Neuroendocrine Tumors: Rethinking Single-Analyte ApproachPaweł Komarnicki, Paweł Gut, Maja Cieślewicz, et al.
Polish Archives of Internal Medicine|January 7, 2025
Comparison of models predicting efficacy of radioiodine therapy in patients with differentiated thyroid cancerMartyna Borowczyk, Elżbieta Jodłowska-Siewert, Dorota Filipowicz, et al.
Pageof 2